SI2922563T1 - CD44V6-pridobljeni peptidi za zdravljenje metastazirajočih rakov - Google Patents

CD44V6-pridobljeni peptidi za zdravljenje metastazirajočih rakov

Info

Publication number
SI2922563T1
SI2922563T1 SI201331649T SI201331649T SI2922563T1 SI 2922563 T1 SI2922563 T1 SI 2922563T1 SI 201331649 T SI201331649 T SI 201331649T SI 201331649 T SI201331649 T SI 201331649T SI 2922563 T1 SI2922563 T1 SI 2922563T1
Authority
SI
Slovenia
Prior art keywords
cd44v6
derived peptides
metastasizing cancers
treating metastasizing
treating
Prior art date
Application number
SI201331649T
Other languages
English (en)
Slovenian (sl)
Inventor
Veronique Orian-Rousseau
Alexandra Matzke
Helmut Ponta
Original Assignee
Karlsruher Institut Fuer Technologie
Amcure Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsruher Institut Fuer Technologie, Amcure Gmbh filed Critical Karlsruher Institut Fuer Technologie
Publication of SI2922563T1 publication Critical patent/SI2922563T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201331649T 2012-11-21 2013-11-21 CD44V6-pridobljeni peptidi za zdravljenje metastazirajočih rakov SI2922563T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1220889.8A GB201220889D0 (en) 2012-11-21 2012-11-21 CD44v6-derived peptides for treating metastasizing cancers
EP13798617.0A EP2922563B1 (en) 2012-11-21 2013-11-21 Cd44v6-derived peptides for treating metastasizing cancers
PCT/EP2013/074404 WO2014079943A1 (en) 2012-11-21 2013-11-21 Cd44v6-derived peptides for treating metastasizing cancers

Publications (1)

Publication Number Publication Date
SI2922563T1 true SI2922563T1 (sl) 2020-04-30

Family

ID=47521460

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331649T SI2922563T1 (sl) 2012-11-21 2013-11-21 CD44V6-pridobljeni peptidi za zdravljenje metastazirajočih rakov

Country Status (13)

Country Link
US (1) US9593146B2 (https=)
EP (1) EP2922563B1 (https=)
JP (1) JP2016501858A (https=)
AU (1) AU2013349703B2 (https=)
CA (1) CA2892147A1 (https=)
DK (1) DK2922563T3 (https=)
ES (1) ES2765037T3 (https=)
GB (1) GB201220889D0 (https=)
HU (1) HUE047126T2 (https=)
IL (1) IL238606B (https=)
LT (1) LT2922563T (https=)
SI (1) SI2922563T1 (https=)
WO (1) WO2014079943A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
EP3466963A1 (en) 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof
KR102194025B1 (ko) 2017-12-15 2020-12-22 경북대학교 산학협력단 CD44v6에 결합하는 펩타이드 및 이의 용도
US11744883B2 (en) 2017-12-22 2023-09-05 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
EP4464714A1 (en) 2023-05-19 2024-11-20 Karlsruher Institut für Technologie Screening method for cell-repelling peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696229A (en) 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
EP1258255A1 (en) 2001-05-18 2002-11-20 Boehringer Ingelheim International GmbH Conjugates of an antibody to CD44 and a maytansinoid
JP2003089700A (ja) 2001-09-18 2003-03-28 Life Science Management:Kk ペプチド
EP1417974A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
AR046774A1 (es) 2003-12-24 2005-12-21 Boehringer Ingelheim Pharma Formulacion liofilizada de conjugados de anticuerpos
EP1647556B1 (en) * 2004-10-14 2010-05-19 Karlsruher Institut für Technologie Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors
EP2218457B1 (en) * 2009-02-16 2011-09-07 Karlsruher Institut für Technologie CD44v6 peptides as inhibitors of bacterial infections
EP2266593A1 (en) * 2009-06-24 2010-12-29 Karlsruher Institut für Technologie Use of CD44v6 in the treatment of ophthalmic diseases
WO2011022335A1 (en) * 2009-08-21 2011-02-24 Mount Sinai School Of Medicine Of New York University Methods of using cd44 fusion proteins to treat cancer

Also Published As

Publication number Publication date
GB201220889D0 (en) 2013-01-02
WO2014079943A1 (en) 2014-05-30
ES2765037T3 (es) 2020-06-05
HUE047126T2 (hu) 2020-04-28
DK2922563T3 (da) 2020-01-20
EP2922563A1 (en) 2015-09-30
IL238606A0 (en) 2015-06-30
LT2922563T (lt) 2020-03-25
US9593146B2 (en) 2017-03-14
IL238606B (en) 2019-07-31
AU2013349703B2 (en) 2016-12-22
AU2013349703A1 (en) 2015-07-09
JP2016501858A (ja) 2016-01-21
EP2922563B1 (en) 2019-10-30
CA2892147A1 (en) 2014-05-30
US20150183826A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
IL272206A (en) Combined treatment for cancer
IL267242B (en) Cancer treatment
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
SG11201603050TA (en) Methods for treating cancers
PL2876447T3 (pl) Sposób wykrywania nowotworu
IL228644A0 (en) Cancer treatment methods
GB2502503B (en) Luggage apparatus
HRP20160851T1 (hr) Prediktori za liječenje karcinoma
IL239031A0 (en) Combined therapy for the treatment of her2-positive cancers
IL238606A0 (en) CD44v6-derivative peptides for the treatment of cancer metastases
SG11201502584XA (en) Peptides and methods for treating cancer
IL232479A0 (en) Combined treatment of ovarian cancer
DK2872176T3 (en) Cancer treatment
EP2934500A4 (en) COMBINATION THERAPY AGAINST CANCER
ZA201504169B (en) Anti-adam28 antibody for treating cancer
GB201220901D0 (en) CD44v6-derived peptides for treating pancreatic cancer
GB201220891D0 (en) CD44v6-derived peptides for treating breast cancers
GB201222563D0 (en) Cancer treatment
EP2854774A4 (en) METHODS OF TREATING INSOMNIA
IL239231A0 (en) Combined cancer treatment
GB201321531D0 (en) Treatment for cancers
GB201118153D0 (en) Therapies for cancers
GB201215167D0 (en) Sanding apparatus
IL228629A0 (en) Cancer detection
GB201118482D0 (en) Treating tumours